Patients are randomized in a @:@ ratio ( @-@days post-transplantation ) to receive everolimus ( trough levels @-@ng / mL ) with reduced tacrolimus ( trough levels < @ng/mL ) , or standard tacrolimus ( trough levels @-@ng / mL ) after entering a run-in period ( @-@days post-transplantation ) .